Stratton Management’s Celgene Corp CELG Stock Holding History

Stratton Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$473K	Sell	3,950 -1,750	-31%	-$202K	0.06%	180
2015 Q3	$617K	Buy	5,700 +900	+19%	+$112K	0.07%	174
2015 Q2	$556K	Sell	4,800 -220	-4%	-$25.2K	0.02%	272
2015 Q1	$579K	Hold	5,020	–	–	0.02%	284
2014 Q4	$562K	Buy	5,020 +550	+12%	+$58K	0.02%	279
2014 Q3	$424K	Sell	4,470 -550	-11%	-$49.6K	0.02%	287
2014 Q2	$431K	Hold	5,020	–	–	0.02%	296
2014 Q1	$350K	Buy	5,020 +100	+2%	+$7.92K	0.02%	303
2013 Q4	$416K	Buy	4,920 +1,520	+45%	+$120K	0.02%	297
2013 Q3	$262K	Buy	+3,400	New	+$238K	0.01%	319

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Stratton Management's CELG Position: Q4 2015 in Review

Stratton Management reduced its Celgene Corp (CELG) stake by 31% in Q4 2015, selling an estimated $202K and leaving 3,950 shares worth $473K. The position accounts for 0.06% of the portfolio, ranked #180.

Stratton Management first reported a position in CELG in Q3 2013 and has held it in 10 quarters since. The position peaked at $617K in Q3 2015. 1,246 funds tracked by Wall St. Rank hold CELG as of Q4 2015.

Stratton Management held 3,950 shares of Celgene Corp worth $473K as of Q4 2015.
Stratton Management sold 1,750 Celgene Corp shares in Q4 2015, an estimated $202K.
Celgene Corp made up 0.06% of Stratton Management's portfolio in Q4 2015, its #180 holding.
Stratton Management first reported a position in Celgene Corp in Q3 2013 and has held it in 10 quarters since.
Stratton Management's Celgene Corp position peaked at $617K in Q3 2015.
1,246 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2015.

Based on Stratton Management's 13F filing for Q4 2015, filed 11 Feb 2016.